Literature DB >> 7705163

Bronchiolitis obliterans in single-lung transplant recipients.

S D Nathan1, D J Ross, M J Belman, S Shain, J D Elashoff, R M Kass, S K Koerner.   

Abstract

The presentation and clinical course of bronchiolitis obliterans (BO) in single-lung transplant (SLT) recipients has thus far not been well described. We retrospectively analyzed the serial spirometry of 15 SLT patients with BO. All the patients fulfilled the criteria for BO syndrome, and 11 of the 15 had histologically documented BO. Based on serial FEV1 analysis, we identified three patterns of presentation and progression of BO. The first pattern (n = 6) was characterized by a rapid onset and a relentless progressive course; the second pattern (n = 5) was characterized by a similar rapid onset and initial rapid decline, but was followed by stabilization in lung function; the third pattern (n = 4) was characterized by an insidious onset and course. In all patients, a permanent reduction in the mean forced expiratory flow during the middle half of the forced vital capacity appeared to be an early sensitive index for the development of BO. An appreciation of these different modes of presentation and progression of BO is potentially important in the assessment of prognosis and management of the SLT recipient.

Entities:  

Mesh:

Year:  1995        PMID: 7705163     DOI: 10.1378/chest.107.4.967

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients.

Authors:  C Ashley Finlen Copeland; Laurie D Snyder; David W Zaas; W Jackson Turbyfill; W Austin Davis; Scott M Palmer
Journal:  Am J Respir Crit Care Med       Date:  2010-05-27       Impact factor: 21.405

2.  CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients.

Authors:  Sean M Studer; M Patricia George; Xuehai Zhu; Yifang Song; Vincent G Valentine; Michael W Stoner; Jigme Sethi; Chad Steele; Steven R Duncan
Journal:  Am J Respir Crit Care Med       Date:  2008-07-10       Impact factor: 21.405

3.  Longitudinal Forced Vital Capacity Monitoring as a Prognostic Adjunct after Lung Transplantation.

Authors:  Elizabeth A Belloli; Xin Wang; Susan Murray; Ginia Forrester; Adrian Weyhing; Jules Lin; Tammy Ojo; Vibha N Lama
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

4.  Parametric Response Mapping as an Imaging Biomarker in Lung Transplant Recipients.

Authors:  Elizabeth A Belloli; Irina Degtiar; Xin Wang; Gregory A Yanik; Linda J Stuckey; Stijn E Verleden; Ella A Kazerooni; Brian D Ross; Susan Murray; Craig J Galbán; Vibha N Lama
Journal:  Am J Respir Crit Care Med       Date:  2017-04-01       Impact factor: 21.405

5.  Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.

Authors:  Raksha Jain; Ramsey R Hachem; Matthew R Morrell; Elbert P Trulock; Murali M Chakinala; Roger D Yusen; Howard J Huang; Thalachallour Mohanakumar; G Alexander Patterson; Michael J Walter
Journal:  J Heart Lung Transplant       Date:  2010-02-04       Impact factor: 10.247

Review 6.  Bronchiolitis obliterans.

Authors:  Petey Laohaburanakit; Andrew Chan; Roblee P Allen
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

7.  Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.

Authors:  Vibha N Lama; Susan Murray; Robert J Lonigro; Galen B Toews; Andrew Chang; Christine Lau; Andrew Flint; Kevin M Chan; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2007-03-08       Impact factor: 21.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.